Home › NDC Lookup › RxCUI directory › RxCUI 2397991

Nifurtimox 30 MG Oral Tablet [Lampit] — RxCUI 2397991

RxNorm drug concept · Semantic branded drug
RxCUI 2397991 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2397991
Official nameNifurtimox 30 MG Oral Tablet [Lampit]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asLampit 30 MG Oral Tablet
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Nifurtimox: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Chagas disease is a parasitic infection caused by a microscopic organism called Trypanosoma cruzi. It's spread mainly through insect bites in certain parts of Latin America. Withou...
  • What exactly is Chagas disease, and why does my child need this medicine?
  • Yes, every dose — all three times a day — must be taken with food. This isn't just a suggestion. Taking Lampit with food significantly increases the amount of medicine your child a...
  • Does my child have to take this with food every single time?
📖 Read our full Nifurtimox guide →

🕸️ Concept Web — How Nifurtimox 30 MG Oral Tablet [Lampit] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Nifurtimox 30 MG Oral Tablet [Lampit] RxCUI 2397991

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Nifurtimox 7421
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Lampit 2397986
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Nifurtimox Oral Tablet 446700
    • Nifurtimox Oral Product 1159226
    • Nifurtimox Pill 1159227
    • Nifurtimox Oral Tablet [Lampit] 2397988
    • Lampit Oral Product 2397989
    • Lampit Pill 2397990
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Nifurtimox 30 MG Oral Tablet SCD · 2395842
  • Nifurtimox 30 MG SCDC · 2395841
  • Nifurtimox Oral Tablet SCDF · 446700
  • Nifurtimox Oral Product SCDG · 1159226
  • Nifurtimox Pill SCDG · 1159227

Brand-Name Concepts

  • Nifurtimox 30 MG [Lampit] SBDC · 2397987
  • Nifurtimox Oral Tablet [Lampit] SBDF · 2397988
  • Lampit Oral Product SBDG · 2397989
  • Lampit Pill SBDG · 2397990
  • Lampit BN · 2397986

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2397991 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50419-0750-01 1 BOTTLE in 1 CARTON (50419-750-01) / 100 TABLET, FILM COAT... LAMPIT Bayer HealthCare Pharmaceuticals Inc. 2020-10-01
50419-0751-01 1 BOTTLE in 1 CARTON (50419-751-01) / 100 TABLET, FILM COAT... LAMPIT Bayer HealthCare Pharmaceuticals Inc. 2020-10-01
Observed labelers: Bayer HealthCare Pharmaceuticals Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.